870822-56-3Relevant articles and documents
Optimizing phenylethylphosphonamidates for the inhibition of prostate-specific membrane antigen
Wone, David W.G.,Rowley, Jennifer A.,Garofalo, Albert W.,Berkman, Clifford E.
, p. 67 - 76 (2006)
A series of eight N-2-phenylethylphosphonyl derivatives of glutamic acid was prepared to determine if the inhibitory potency of a phenylethylphosphonyl derivative of glutamic acid against prostate-specific membrane antigen (PSMA) could be improved through